13 Oct 2020 Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis Member news
30 Sep 2020 Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial Member news
29 Sep 2020 Celyad Oncology announces clinical trial collaboration to evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in patients with Microsatellite Stable mCRC Member news
24 Sep 2020 Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate Member news
22 Sep 2020 Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study Member news
11 Sep 2020 Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients Member news
01 Sep 2020 Oxurion NV reports first patient dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
11 Aug 2020 Precigen ActoBio announces positive topline results from Phase 1b study of AG019 ActoBiotics Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
